Страна: Великобритания
Язык: английский
Источник: VMD (Veterinary Medicines Directorate)
Infectious bronchitis virus
Zoetis UK Limited
QI01AD07
Infectious bronchitis virus
Lyophilisate for oculonasal suspension
POM-V - Prescription Only Medicine – Veterinarian
Chickens
Live Viral Vaccine
Authorized
2013-06-27
Revised: April 2023 AN: 01284/2022 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Poulvac IB QX lyophilisate for oculonasal suspension for chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose contains: ACTIVE SUBSTANCE: Live attenuated Avian Infectious Bronchitis Virus, strain L1148 10 3.0 – 10 5.0 EID 50 *. *EID50 = 50% Embryo Infective Dose. EXCIPIENTS: QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS D-mannitol Gelatine Myo-Inositol Peptone Water for injection Off-white, beige coloured lyophilisate. 3. CLINICAL INFORMATION 3.1 TARGET SPECIES Chickens. 3.2 INDICATIONS FOR USE FOR EACH TARGET SPECIES For active immunisation of chickens in order to reduce respiratory signs of Infectious Bronchitis caused by QX-like variants of Infectious Bronchitis virus. Onset of immunity: 3 weeks after vaccination. Duration of immunity: 63 days after vaccination. 3.3 CONTRAINDICATIONS None. 3.4 SPECIAL WARNINGS The vaccine virus is capable of spreading to in contact birds for a minimum of 14 days after vaccination and appropriate care should be taken to separate vaccinated Revised: April 2023 AN: 01284/2022 Page 2 of 5 from non-vaccinated chickens. Precautionary measures should be taken to prevent spreading to wildlife. Cleaning and disinfection of the premises after vaccination is advisable. This vaccine should only be used after it has been established that the QX-like IBV variant strain is epidemiologically relevant. It is important to avoid introduction of the IB QX vaccine virus into premises in which the wild type strain is not present. The IB QX vaccine should only be applied in hatcheries if adequate controls are in place to avoid the spread of the vaccine virus to birds that will be transported to non-IB QX exposed flocks. The vaccine has been demonstrated to provide protection against QX-like variant. The protection against other circulating IB strains has not been investigated. As there is a small range between the efficacious vaccine dose and a non- Прочитать полный документ